Increased islet antigen presentation leads to type-1 diabetes in mice with autoimmune susceptibility

European Journal of Immunology

Volumn 34, Issue 4, 2004, Pages 1031-1040

  Judkowski, Valeria ^a   Krakowski, Michelle ^a,c   Rodriguez, Enrique ^a   Mocnick, Lorraine ^a   Santamaria, Pere ^b   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c Canadian Institutes of Health Research   (Canada)

Author keywords

Antigen presentation; Diabetes

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL MATURATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; IMMUNOREACTIVITY; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; CYTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PATHOLOGY; SPLEEN;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED NOD; SPLEEN;

EID: 3843080902     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324563     Document Type: Article

References (43)

1. Castano, L. and Eisenbarth, G. S., Typed diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 1990. 8: 647-679.
2. Tochino, Y., The NOD mouse as a model of type I diabetes. Crit. Rev. Immunol. 1987. 8: 49-81.
3. + T cells. J. Exp. Med. 1987. 166: 823-832.
4. + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J. Immunol. 1988. 140: 52-58.
5. + T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur. J. Immunol. 1992. 22: 2387-2393.
6. + T cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 1993. 42: 44-55.
7. + cytotoxic T cell clone recognizes GAD65 and causes insulitis. J. Autoimmun. 2003. 20: 97-109.
8. Verdaguer, J., Schmidt, D., Amrani, A., Anderson, B., Averill, N. and Santamaria, P., Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 1997. 186: 1663-1676.
9. + islet-specific T cell clone. Science 1990. 249: 1433-1436.
10. Haskins, K., Portas, M., Bergman, B., Lafferty, K. and Bradley, B., Pancreatic islet-specific T cell clones from nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 1989. 86: 8000-8004.
11. Bradley, B. J., Wang, Y. Y., Lafferty, K. J. and Haskins, K., In vivo activity of an islet-reactive T cell clone. J. Autoimmun. 1990. 3: 449-456.
12. Vanderlugt, C. J. and Miller, S. D., Epitope spreading. Curr. Opin. Immunol. 1996. 8: 831-836.
13. Lehmann, P. V., Sercarz, E. E., Forsthuber, T., Dayan, C. M. and Gammon, G., Determinant spreading and the dynamics of the autoimmune T cell repertoire. Immunol. Today 1993. 14: 203-208.
14. Serreze, D. V., Chapman, H. D., Varnum, D. S., Hanson, M. S., Reifsnyder, P. C., Richard, S. D., Fleming, S. A., Leiter, E. H. and Shultz, L. D., B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. J. Exp. Med. 1996. 184: 2049-2053.
15. + T cell responses. Nat. Med. 2001. 7: 206-214.
16. Feili-Hariri, M., Dong, X., Alber, S. M., Watkins, S. C., Salter, R. D. and Morel, P. A., Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes 1999. 48: 2300-2308.
17. Clare-Salzler, M. J., Brooks, J., Chai, A., Van Herle, K. and Anderson, C., Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J. Clin. Invest. 1992. 90: 741-748.
18. Morel, P. A. and Feili-Hariri, M., How do dendritic cells prevent autoimmunity? Trends Immunol. 2001. 22: 546-547.
19. Vial, T. and Descotes, J., Immune-mediated side-effects of cytokines in humans. Toxicology 1995. 105: 31-57.
20. Biondo, M., Nasa, Z., Marshall, A., Toh, B. H. and Alderuccio, F., Local transgenic expression of granulocyte macrophage-colony stimulating factor initiates autoimmunity. J. Immunol. 2001. 166: 2090-2099.
21. Krakowski, M., Abdelmalik, R., Mocnik, L., Krahl, T. and Sarvetnick, N., Granulocyte macrophage-colony stimulating factor (GM-CSF) recruits immune cells to the pancreas and delays STZ-induced diabetes. J. Pathol. 2002. 196: 103-112.
22. Bondanza, A., Zimmermann, V. S., Dell'Antonio, G., Dal Cin, E., Capobianco, A., Sabbadini, M. G., Manfredi, A. A. and Rovere-Querini, P., Cutting edge: dissociation between autoimmune response and clinical disease after vaccination with dendritic cells. J. Immunol. 2003. 170: 24-27.
23. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. and Steinman, R. M., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992. 176: 1693-1702.
24. Kelly, K. A., Lucas, K., Hochrein, H., Metcalf, D., Wu, L. and Shortman, K., Development of dendritic cells in culture from human and murine thymic precursor cells. Cell. Mol. Biol. (Noisy-le-grand) 2001. 47: 43-54.
25. Wada, H., Noguchi, Y., Marino, M. W., Dunn, A. R. and Old, L. J., T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice. Proc. Natl. Acad. Sci. USA 1997. 94: 12557-12561.
26. Katz, J. D., Wang, B., Haskins, K., Benoist, C. and Mathis, D., Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993. 74: 1089-1100.
27. Alvaro-Gracia, J. M., Zvaifler, N. J. and Firestein, G. S., Cytokines in chronic inflammatory arthritis. IV. Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: a possible role in rheumatoid arthritis. J. Exp. Med. 1989. 170: 865-875.
28. Fischer, H. G. and Reichmann, G., Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J. Immunol. 2001. 166: 2717-2726.
29. Morrissey, P. J., Bressler, L., Park, L. S., Alpert, A. and Gillis, S., Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J. Immunol. 1987. 139: 1113-1119.
30. von Zahn, J., Moller, T., Kettenmann, H. and Nolte, C., Microglial phagocytosis is modulated by pro- and anti-inflammatory cytokines. Neuroreport 1997. 8: 3851-3856.
31. Lyons, A. B., Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 2000. 243: 147-154.
32. Alderuccio, F., Biondo, M. and Toh, B. H., Organ-specific autoimmunity in granulocyte macrophage-colony stimulating factor (GM-CSF) deficient mice. Autoimmunity 2002. 35: 67-73.
33. Campbell, I. K., Rich, M. J., Bischof, R. J., Dunn, A. R., Grail, D. and Hamilton, J. A., Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 1998. 161: 3639-3644.
34. Hamilton, J. A., GM-CSF in inflammation and autoimmunity. Trends Immunol. 2002. 23: 403-408.
35. Salomon, B. and Bluestone, J. A., Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 2001. 19: 225-252.
36. Ablamunits, V., Elias, D. and Cohen, I. R., The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse. Clin. Exp. Immunol. 1999. 115: 260-267.
37. Boitard, C., Yasunami, R., Dardenne, M. and Bach, J. F., T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 1989. 169: 1669-1680.
38. Lang, T. J., Nguyen, P., Papadimitriou, J. C. and Via, C. S., Increased severity of murine lupus in female mice is due to enhanced expansion of pathogenic T cells. J. Immunol. 2003. 171: 5795-5801.
39. Grossman, C. J., Regulation of the immune system by sex steroids. Endocr. Rev. 1984. 5: 435-455.
40. Wilder, R. L., Neuroendocrine-immune system interactions and autoimmunity. Annu. Rev. Immunol. 1995. 13: 307-338.
41. Krakowski, M. L., Kritzik, M. R., Jones, E. M., Krahl, T., Lee, J., Arnush, M., Gu, D. and Sarvetnick, N., Pancreatic expression of keratinocyte growth factor leads to differentiation of islet hepatocytes and proliferation of duct cells. Am. J. Pathol. 1999. 154: 683-691.
42. Mueller, R., Krahl, T., and Sarvetnick, N., Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 1996. 184: 1093-1099.
43. Judkowski, V., Pinilla, C., Schroder, K., Tucker, L., Sarvetnick, and Wilson, D. B., Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J. Immunol. 2001. 166: 908-917.